TH

Thalassa Holdings Ltd.

A holding company active in property rentals and marine seismic & defense R&D.

THAL | IL

Overview

Corporate Details

ISIN(s):
VGG878801114
LEI:
2138002739WFQPLBEQ42
Country:
Virgin Islands (British)
Address:
FOLIO CHAMBERS, VG1110 ROAD TOWN
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Thalassa Holdings Ltd. is a holding company engaged in international business activities. The company's operations are primarily focused on two segments: Rental Income, derived from its property interests, and Product Development. The Product Development segment concentrates on marine seismic and defense research and development, including geophysical project management, related services, and the supply of equipment. The company's strategic goal is to generate long-term shareholder value by deploying capital and expertise into investment opportunities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-29 11:39
M&A Activity
Thalassa Holdings Ltd: Trading Update
English 9.9 KB
2025-10-29 11:39
M&A Activity
Thalassa Holdings Ltd: Trading Update
English 11.4 KB
2025-10-15 09:35
Board/Management Information
Thalassa Holdings Ltd: Thalassa Board reaches agreement with Newmark Security p…
English 9.1 KB
2025-10-15 09:35
Board/Management Information
Thalassa Holdings Ltd: Thalassa Board reaches agreement with Newmark Security p…
English 10.5 KB
2025-10-08 08:30
Regulatory News Service
Thalassa Holdings Ltd: Letter to Newmark Security plc (NWT) Shareholders
English 562.7 KB
2025-10-08 08:30
Major Shareholding Notification
Thalassa Holdings Ltd: Letter to Newmark Security plc (NWT) Shareholders
English 722.8 KB
2025-09-29 10:57
Board/Management Information
Thalassa Holdings Ltd: Surgical Innovations Group plc
English 7.9 KB
2025-09-29 08:30
Interim Report
Thalassa Holdings Ltd: 2025 Interim Results
English 408.7 KB
2025-09-29 08:30
Earnings Release
Thalassa Holdings Ltd: 2025 Interim Results
English 496.5 KB

Automate Your Workflow. Get a real-time feed of all Thalassa Holdings Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Thalassa Holdings Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Thalassa Holdings Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

A marketing support firm using a vast consumer panel for data-driven research and PR campaigns.
Japan
4196
Neonode Inc. Logo
Licenses optical sensing and computer vision for HMI in automotive and consumer electronics.
United States of America
NEON
Neovacs Logo
Develops immunotherapy vaccines for autoimmune diseases & invests in BioTech/MedTech companies.
France
ALNEV
Mineral explorer of rare earths, niobium, uranium, and copper assets in Australia and Zambia.
Australia
NFM
NexGen Energy Ltd. Logo
Uranium exploration company developing a high-grade mine to supply global clean energy fuel.
United States of America
NXE
Nexxen International Ltd. Logo
End-to-end programmatic ad platform for advertisers, agencies, & publishers, specializing in video & CTV.
United States of America
NEXN
NFL Biosciences Logo
Develops botanical drug candidates to treat smoking and alcohol addictions.
France
ALNFL
NGS Group Logo
Nordic staffing & recruitment for healthcare, education, and social services sectors.
Sweden
NGS
Nihon M&A Center Holdings Inc. Logo
M&A advisory firm specializing in brokerage and consulting for Japanese SMEs, including cross-border deals.
Japan
2127
Noile-Immune Biotech Inc. Logo
Developing PRIME technology-enhanced CAR-T cell immunotherapies for treating solid tumors.
Japan
4893

Talk to a Data Expert

Have a question? We'll get back to you promptly.